Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-30

Clinical Trial Update: Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation [Phase 3]

View source ↗

Summary

Phase 3 trial of linaclotide in irritable bowel syndrome with constipation has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linzess (linaclotide)

Snippet

Sponsor: Forest Laboratories | Conditions: Irritable Bowel Syndrome Characterized by Constipation | Phase 3 | Status: COMPLETED | Results posted: 2013-01-30